This role of adiponectin in the inflammatory process is particularly positive in patients with metabolic diseases such as type 2 diabetes mellitus and obesity, who have shown low-grade chronic inflammation and low serum adiponectin concentrations [4]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.